FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033142195> ?p ?o ?g. }

• W3033142195 endingPage "110322" @default.
• W3033142195 startingPage "110322" @default.
• W3033142195 abstract "Streptomyces Sp FJS31-2 is a strain isolated from special habitat soils in the early stage of our laboratory for producing a new type of halogenated type II polyketide antibiotic with good anti-MRSA activity. In this experiment, a variety of chromatographic and spectroscopic methods was used to isolate and identify a milbemycin compound VM48130 from the ethyl acetate extract of the fermentation products. To investigate its bioactivity, Cell Counting Kit-8 (CCK-8) assay was used to test the cytotoxic activity of the compound against a variety of cancer cells (human liver cancer cell line MHCC97H and SK-Hep1, human nasopharyngeal carcinoma cell line CNE1, mouse melanoma cell line B16, human colon cancer cell line LOVO, human lung adenocarcinoma cell line A549) and normal cells (human bronchial epithelial cell line 16HBE, human normal liver cell line L02, human nasopharyngeal epithelial cell line NP69). The results showed that the compound had significant cytotoxic activity against the above cancer cells, and the IC50 values were 21.96 ± 1.45, 22.18 ± 0.55, 19.42 ± 0.71, 18.61 ± 1.68, 18.62 ± 0.67, 18.52 ± 0.64 μM, respectively. Furthermore, the CCK-8 method was used to evaluate the compound's reversal of cisplatin resistance in multidrug resistant cisplatin-resistant human lung adenocarcinoma (A549/DDP) cells. The results indicated that when the compound concentration was 0.5 μM, the reversal fold (RF) reached 6.25 and showed a dose-dependent effect. At 5 μM, the RF reached 8.35, which was approximately equivalent to the reversal effect of the positive drug verapamil at the same concentration. The expression of MDR1, MRP1, LRP, MAST1 resistance genes and the corresponding proteins were analyzed by quantitative RT-PCR and Western blot assay, and found that the compound could significantly down-regulate the expression of these genes and proteins. These results indicated that VM48130 had the potential of being a lead compound for the treatment or adjuvant treatment of cancer." @default.
• W3033142195 created "2020-06-12" @default.
• W3033142195 creator A5005894447 @default.
• W3033142195 creator A5006979027 @default.
• W3033142195 creator A5024256437 @default.
• W3033142195 creator A5036279492 @default.
• W3033142195 creator A5074193129 @default.
• W3033142195 creator A5079173563 @default.
• W3033142195 creator A5085984129 @default.
• W3033142195 date "2020-08-01" @default.
• W3033142195 modified "2023-10-01" @default.
• W3033142195 title "A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells" @default.
• W3033142195 cites W147439079 @default.
• W3033142195 cites W1963577410 @default.
• W3033142195 cites W2003523903 @default.
• W3033142195 cites W2006434892 @default.
• W3033142195 cites W2006810880 @default.
• W3033142195 cites W2010014978 @default.
• W3033142195 cites W2017192690 @default.
• W3033142195 cites W2022259545 @default.
• W3033142195 cites W2039278712 @default.
• W3033142195 cites W2050028164 @default.
• W3033142195 cites W2064551035 @default.
• W3033142195 cites W2066993274 @default.
• W3033142195 cites W2092049999 @default.
• W3033142195 cites W2110712892 @default.
• W3033142195 cites W2119472087 @default.
• W3033142195 cites W2146133266 @default.
• W3033142195 cites W2157393167 @default.
• W3033142195 cites W2166823402 @default.
• W3033142195 cites W2169302611 @default.
• W3033142195 cites W2233475645 @default.
• W3033142195 cites W2326929269 @default.
• W3033142195 cites W2396972395 @default.
• W3033142195 cites W2542082309 @default.
• W3033142195 cites W2586221754 @default.
• W3033142195 cites W2766196487 @default.
• W3033142195 cites W2883776565 @default.
• W3033142195 cites W2887326809 @default.
• W3033142195 cites W2896444521 @default.
• W3033142195 cites W4241711063 @default.
• W3033142195 cites W4249508367 @default.
• W3033142195 doi "https://doi.org/10.1016/j.biopha.2020.110322" @default.
• W3033142195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32505822" @default.
• W3033142195 hasPublicationYear "2020" @default.
• W3033142195 type Work @default.
• W3033142195 sameAs 3033142195 @default.
• W3033142195 citedByCount "8" @default.
• W3033142195 countsByYear W30331421952021 @default.
• W3033142195 countsByYear W30331421952022 @default.
• W3033142195 countsByYear W30331421952023 @default.
• W3033142195 crossrefType "journal-article" @default.
• W3033142195 hasAuthorship W3033142195A5005894447 @default.
• W3033142195 hasAuthorship W3033142195A5006979027 @default.
• W3033142195 hasAuthorship W3033142195A5024256437 @default.
• W3033142195 hasAuthorship W3033142195A5036279492 @default.
• W3033142195 hasAuthorship W3033142195A5074193129 @default.
• W3033142195 hasAuthorship W3033142195A5079173563 @default.
• W3033142195 hasAuthorship W3033142195A5085984129 @default.
• W3033142195 hasBestOaLocation W30331421951 @default.
• W3033142195 hasConcept C109316439 @default.
• W3033142195 hasConcept C121608353 @default.
• W3033142195 hasConcept C126322002 @default.
• W3033142195 hasConcept C153911025 @default.
• W3033142195 hasConcept C154317977 @default.
• W3033142195 hasConcept C185592680 @default.
• W3033142195 hasConcept C202751555 @default.
• W3033142195 hasConcept C2776694085 @default.
• W3033142195 hasConcept C2778239845 @default.
• W3033142195 hasConcept C2778997737 @default.
• W3033142195 hasConcept C2781182431 @default.
• W3033142195 hasConcept C509974204 @default.
• W3033142195 hasConcept C54355233 @default.
• W3033142195 hasConcept C55493867 @default.
• W3033142195 hasConcept C71924100 @default.
• W3033142195 hasConcept C81729549 @default.
• W3033142195 hasConcept C81885089 @default.
• W3033142195 hasConcept C86803240 @default.
• W3033142195 hasConcept C89423630 @default.
• W3033142195 hasConceptScore W3033142195C109316439 @default.
• W3033142195 hasConceptScore W3033142195C121608353 @default.
• W3033142195 hasConceptScore W3033142195C126322002 @default.
• W3033142195 hasConceptScore W3033142195C153911025 @default.
• W3033142195 hasConceptScore W3033142195C154317977 @default.
• W3033142195 hasConceptScore W3033142195C185592680 @default.
• W3033142195 hasConceptScore W3033142195C202751555 @default.
• W3033142195 hasConceptScore W3033142195C2776694085 @default.
• W3033142195 hasConceptScore W3033142195C2778239845 @default.
• W3033142195 hasConceptScore W3033142195C2778997737 @default.
• W3033142195 hasConceptScore W3033142195C2781182431 @default.
• W3033142195 hasConceptScore W3033142195C509974204 @default.
• W3033142195 hasConceptScore W3033142195C54355233 @default.
• W3033142195 hasConceptScore W3033142195C55493867 @default.
• W3033142195 hasConceptScore W3033142195C71924100 @default.
• W3033142195 hasConceptScore W3033142195C81729549 @default.
• W3033142195 hasConceptScore W3033142195C81885089 @default.
• W3033142195 hasConceptScore W3033142195C86803240 @default.
• W3033142195 hasConceptScore W3033142195C89423630 @default.

• next